CD14 and chronic myelogenous leukemia, BCR-ABL1 positive: Monocytes displayed phenotypic conversion into CD14+HLA‐DR− only in conditions with CML serum; the percentage of M‐MDSC significantly increased by 29 ± 13%, P = 0.0006 (Fig. 3A).